Blake Coblentz was quoted in Bloomberg Law about how the COVID-19 pandemic is impacting a cross-section of practice groups and industries. The FDA, for example, announced May 11 that companies developing COVID-19 virus and antibody tests must obtain an Emergency Use Authorization from the agency. The FDA scrapped an earlier policy allowing tests to be launched without an authorization. The best advice for dealing with these challenges is to “work with the FDA,” said Blake.

To read more of this article, click here.